Vivani Medical, Inc.
VANI
$1.05
$0.021.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.93M | 8.28M | 8.88M | 9.85M | 10.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.68M | 24.43M | 25.27M | 26.59M | 26.97M |
| Operating Income | -24.68M | -24.43M | -25.27M | -26.59M | -26.97M |
| Income Before Tax | -23.49M | -23.46M | -24.20M | -25.37M | -25.65M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.49 | -23.46 | -24.20 | -25.37 | -25.65 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.49M | -23.46M | -24.20M | -25.37M | -25.65M |
| EBIT | -24.68M | -24.43M | -25.27M | -26.59M | -26.97M |
| EBITDA | -24.28M | -24.03M | -24.90M | -26.24M | -26.61M |
| EPS Basic | -0.43 | -0.44 | -0.46 | -0.50 | -0.50 |
| Normalized Basic EPS | -0.27 | -0.28 | -0.29 | -0.31 | -0.32 |
| EPS Diluted | -0.43 | -0.44 | -0.46 | -0.50 | -0.50 |
| Normalized Diluted EPS | -0.27 | -0.28 | -0.29 | -0.31 | -0.32 |
| Average Basic Shares Outstanding | 219.89M | 213.50M | 209.09M | 204.86M | 203.41M |
| Average Diluted Shares Outstanding | 219.89M | 213.50M | 209.09M | 204.86M | 203.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |